Ultra-Fast LC/MS/MS in Bioanalysis Using Fused-Core Columns

Ethan R. Badman, Ph.D.
With recent advances in HPLC columns and LC/MS hardware, it is possible to increase the throughput of bioanalytical assays without sacrificing quality. By using fused-core columns, it is possible to decrease the run time from ~4 min to 1 min or less, without the use of UHPLC hardware. High quality methods at high flow rates (1-3 mL/min) using non-ballistic gradients as short as 20 seconds were developed that provide comparable or better performance for accuracy, precision, sensitivity, and specificity than traditional slower LC methods. Data will be presented that show that these assays meet regulatory requirements for bioanalytical work. Limitations in the ultimate speed possible for these assays will also be discussed.
Feb 16 2011
39 mins
Ultra-Fast LC/MS/MS in Bioanalysis Using Fused-Core Columns
More from this community:

Medical Research

  • Live and recorded (443)
  • Upcoming (32)
  • Date
  • Rating
  • Views
  • Biological terror agents are frequently spore-forming bacteria and hardy in the environment, intended to persist despite best efforts at disinfection. This webinar explores the field of UV-C disinfection and the power of pulsed-xenon UV disinfection systems to neutralize such threats. Full spectrum pulsed-xenon UV is lab-tested to deactivate bioterrorism agents in the environment, expanding the options for protecting first responders and armed forces from dangerous pathogens.
  • Visit this page to download our infographic:
    http://www.vitaminsinmotion.com/fileadmin/data/pdf/Infographics/The_Liver_FOR_DIGITAL_05.pdf

    Fatty liver – and the focus is on fatty liver caused by lifestyle, not by alcohol - is a growing issue worldwide. A non-alcoholic fatty liver is frequently associated with obesity, insulin resistance and diabetes type 2. Today, there are approximately 1.5 billion overweight or obese people worldwide, and more than 300 million have diabetes type 2. Non-alcoholic fatty liver is also observed in 16% to 20% of normal weight individuals, and often has no symptoms.

    In this informative webinar, independent expert Dr. Arun Sanyal – a leading scientist from Virginia Commonwealth University – joins DSM’s Dr. Manfred Eggersdorfer, Professor for Healthy Ageing at Groningen University, and Jacob Bauly to present the latest research on the role of vitamin E supplementation in limiting the negative health implications of fatty liver.

    The results of several human studies have demonstrated that vitamin E was found to be effective in reducing the onset and development of a non-alcoholic fatty liver, was safe in the applied dose and did not lead to side effects such as weight gain. Currently, there is no approved drug for the treatment of a non-alcoholic fatty liver. It has been shown that vitamin E directed at a defined daily dose improves the liver condition in non-diabetic adults with a non-alcoholic fatty liver.
  • Key insights on mHealth and Disruption in Pharma, presented by experts.

    •How do new technologies disrupt industries?
    •Why does the network always win?
    •What are some key trends in healthcare technologies?
    •How can pharma leverage these trends?
  • Visit this page to download our infographic:
    http://www.vitaminsinmotion.com/fileadmin/data/pdf/Infographics/The_Liver_FOR_DIGITAL_05.pdf

    Fatty liver – and the focus is on fatty liver caused by lifestyle, not by alcohol - is a growing issue worldwide. A non-alcoholic fatty liver is frequently associated with obesity, insulin resistance and diabetes type 2. Today, there are approximately 1.5 billion overweight or obese people worldwide, and more than 300 million have diabetes type 2. Non-alcoholic fatty liver is also observed in 16% to 20% of normal weight individuals, and often has no symptoms.

    In this informative webinar, independent expert Dr. Arun Sanyal – a leading scientist from Virginia Commonwealth University – joins DSM’s Dr. Manfred Eggersdorfer, Professor for Healthy Ageing at Groningen University, and Jacob Bauly to present the latest research on the role of vitamin E supplementation in limiting the negative health implications of fatty liver.

    The results of several human studies have demonstrated that vitamin E was found to be effective in reducing the onset and development of a non-alcoholic fatty liver, was safe in the applied dose and did not lead to side effects such as weight gain. Currently, there is no approved drug for the treatment of a non-alcoholic fatty liver. It has been shown that vitamin E directed at a defined daily dose improves the liver condition in non-diabetic adults with a non-alcoholic fatty liver.
  • Abstract:
    As a key determinant of drug pharmacokinetics, transporter mediated drug-drug interaction has garnered significant attention from the pharmaceutical industry and regulatory authorities. Corning offers a comprehensive list of tools to support drug transporter studies and recently introduced Corning® TransportoCells™ products to support in vitro assessment of drug interaction with SLC transporters. This new model provides a convenient “thaw and go” cell-based model with robust activity and consistent performance. In this webinar, we will provide an overview of Corning TransportoCells products along with applications for in vitro-to-in vivo correlation. Validation data will also be presented for the newly available TransportoCells products, including OATP1A2, OATP2B1, PEPT1, PEPT2, and NTCP.

    Presenter Biography:
    Dr. Na Li received her B.S degree in Biology from Fudan University, Shanghai, China, and her Ph.D. in Pharmacology from Dartmouth Medical School, Hanover, NH. Her major research focus is on drug transporters, including interspecies differences in hepatobiliary transporters, transporter quantification, and in vitro-to-in vivo extrapolation of drug pharmacokinetics. At Corning, Dr. Li contributes her expertise in in vitro drug transporter technology and its application in drug ADME.
  • As part of its launch year, 2D Materials is helping authors to go further in sharing their research. In the first of our dedicated webinar series for rising stars in the field of 2D materials research, Andres Castellanos-Gomez will present some of his recent work on 'Atomically thin black phosphorus nanodevices’. Andres Castellanos-Gomez, is a Marie Curie Fellow at Delft University and a Visiting Researcher at IMDEA Nanoscience (Madrid, Spain). His research is focused on the study of the mechanical, electrical and optical properties of two-dimensional atomically thin crystals fabricated by exfoliation of bulk-layered crystals.

    The webinar should be of interest to researchers of monolayer and bulk-layered 2D crystals, particularly phosphorene, and their optoelectronic properties.
  • Introduction on what are considered as acceptable extractable and leachable data for submissions. The talk will focus on extractable and leachable study design considerations with examples on single project level. Also, discuss how to evaluate and leverage supplier data if they are available to you. Close with discussion on how to simplify and reduce numbers of E&L studies on entire project or multiple products/lines/buildings level.
  • Interested in treatment adaption? Learn about deformable registration and how it is essential for adaptive therapy. We will bring up common cases where deformable registration can be used, discuss related challenges as well as necessary features for success. You will see RayStation's approach to deformable registration with functionalities like structure propagation, dose deformation, treatment evaluation for delivered fractions and various QA options.

    We have applied to CAMPEP for 1 MPCEC (Medical Physics Continuing Education Credit)
  • Thermal Analysis is often used to investigate pharmaceutical substances. Polymorphism, pseudo-polymorphism, phase diagrams, stability, and purity determination can all be measured by thermal analysis.

    
The four main techniques of thermal analysis, DSC, TGA, TMA, and DMA are ideal for characterizing such substances. The chief advantage is that properties can be measured as a function of the temperature or time over a wide temperature range, from –150 to 1600 °C.

    

In this Webinar, we will show how thermal analysis is used to investigate pharmaceutical substances. We will present some typical examples measured by DSC, TGA, TMA or DMA.
  • Channel
  • Channel profile
  • Interplay of Acetyltransferase EP300 and the Proteasome System in Regulat-Sess.2 May 21 2015 8:00 pm UTC 75 mins
    In the present study, a genome-wide RNA interference screen was combined with an extensive biochemical analysis and quantitative proteomics to better understand the regulation of the heat-shock response (HSR) upon thermal stress. The usage of an endoribonuclease-prepared small interfering RNA (esiRNA) library represented a simple and efficient way to perform RNAi with minimal off-target effects. In the screening experiments novel positive and negative modulators of the stress response were identified, including proteins involved in chromatin remodeling, transcription, mRNA splicing, DNA damage repair, and proteolytic degradation. The diversity of the identified regulators suggests that induction and attenuation of the HSR integrate signals from different cellular pathways and are rather multi-factorial processes than single gene/protein events. The modulator proteins are localized in multiple cellular compartments with the majority having their primary location in the nucleus. A protein-protein interaction analysis revealed a HSR regulatory network, with chromatin modifiers and nuclear protein quality control components occupying hub positions. These observations are supported by quantitative proteomics experiments, which showed specific stress-induced reorganizations of the nuclear proteome, including the transient accumulation of chaperones and proteasomal subunits.
    Moreover, we found that the acetyltransferase EP300 controls the cellular level of activatable HSF1. This involves acetylation of HSF1 at multiple lysines not required for function and results in stabilization of HSF1 against proteasomal turnover. Acetylation of functionally critical lysines during stress serves to fine-tune HSF1 activation. Finally, the nuclear proteasome system functions in attenuating the stress response by degrading activated HSF1 in a manner linked with the clearance of misfolded proteins.
  • Interplay of Acetyltransferase EP300 and the Proteasome System in Regu-Session 1 May 21 2015 12:00 pm UTC 75 mins
    In the present study, a genome-wide RNA interference screen was combined with an extensive biochemical analysis and quantitative proteomics to better understand the regulation of the heat-shock response (HSR) upon thermal stress. The usage of an endoribonuclease-prepared small interfering RNA (esiRNA) library represented a simple and efficient way to perform RNAi with minimal off-target effects. In the screening experiments novel positive and negative modulators of the stress response were identified, including proteins involved in chromatin remodeling, transcription, mRNA splicing, DNA damage repair, and proteolytic degradation. The diversity of the identified regulators suggests that induction and attenuation of the HSR integrate signals from different cellular pathways and are rather multi-factorial processes than single gene/protein events. The modulator proteins are localized in multiple cellular compartments with the majority having their primary location in the nucleus. A protein-protein interaction analysis revealed a HSR regulatory network, with chromatin modifiers and nuclear protein quality control components occupying hub positions. These observations are supported by quantitative proteomics experiments, which showed specific stress-induced reorganizations of the nuclear proteome, including the transient accumulation of chaperones and proteasomal subunits.
    Moreover, we found that the acetyltransferase EP300 controls the cellular level of activatable HSF1. This involves acetylation of HSF1 at multiple lysines not required for function and results in stabilization of HSF1 against proteasomal turnover. Acetylation of functionally critical lysines during stress serves to fine-tune HSF1 activation. Finally, the nuclear proteasome system functions in attenuating the stress response by degrading activated HSF1 in a manner linked with the clearance of misfolded proteins.
  • Duolink in Biomedical Science, Session 2 Apr 28 2015 3:00 pm UTC 75 mins
    Gap junctions (GJs) are large aggregates of intercellular channels that facilitate the diffusion of small molecules and ions between two interacting cells. GJ intercellular channels are formed through the interaction of two half-channels, called hemichannels, composed of oligomerized connexin protein subunits. Both GJs and hemichannels have numerous important physiological and pathological roles in tissue functions including propagation of the action potential in the heart, tumor growth and metastasis, the inflammatory response and adaptive immunity, wound healing, and electrical synaptic transmission in the central nervous system. The most widely expressed connexin isoform is Cx43, and its regulation in the abovementioned processes has been a major focus of GJ research. Over the past two decades protein-protein interaction with the cytoplasmic carboxyl terminus of Cx43 has come to the fore as an endogenous mechanism for controlling the GJ life cycle, channel gating, and channel-independent functions. We have used the Duolink proximity ligation assay (PLA) as a technique to study protein interactions with Cx43 in cultured cells. Two unique aspects of the technology – specifically, subcellular localization and the binary nature of the labeling – in combination with standard immunofluorescent confocal imaging techniques have yielded unexpected insights into GJ ultrastructure, action potential conduction, and the mechanistic regulation of Cx43 trafficking and hemichannel accretion to GJ plaques. In this context, the practical application of, appropriate controls for, and interpretation of Duolink PLAs will be explicated.
  • Duolink in Biomedical Science, Session 1 Apr 28 2015 1:00 am UTC 75 mins
    Gap junctions (GJs) are large aggregates of intercellular channels that facilitate the diffusion of small molecules and ions between two interacting cells. GJ intercellular channels are formed through the interaction of two half-channels, called hemichannels, composed of oligomerized connexin protein subunits. Both GJs and hemichannels have numerous important physiological and pathological roles in tissue functions including propagation of the action potential in the heart, tumor growth and metastasis, the inflammatory response and adaptive immunity, wound healing, and electrical synaptic transmission in the central nervous system. The most widely expressed connexin isoform is Cx43, and its regulation in the abovementioned processes has been a major focus of GJ research. Over the past two decades protein-protein interaction with the cytoplasmic carboxyl terminus of Cx43 has come to the fore as an endogenous mechanism for controlling the GJ life cycle, channel gating, and channel-independent functions. We have used the Duolink proximity ligation assay (PLA) as a technique to study protein interactions with Cx43 in cultured cells. Two unique aspects of the technology – specifically, subcellular localization and the binary nature of the labeling – in combination with standard immunofluorescent confocal imaging techniques have yielded unexpected insights into GJ ultrastructure, action potential conduction, and the mechanistic regulation of Cx43 trafficking and hemichannel accretion to GJ plaques. In this context, the practical application of, appropriate controls for, and interpretation of Duolink PLAs will be explicated.
  • Visualizing DNA Methylation (5mC) on a Specific Genomic Locus (SEPTIN9) 02 Apr 14 2015 3:00 pm UTC 75 mins
    Although there are many techniques to study epigenetic marks such as DNA- and histone-methylation, on a genomic scale, there exists a need in the field to visualize these epigenetic marks at a single genomic locus in individual cells. Such an application requires a highly sensitive detection method. With this aim, a protocol was developed to perform in-situ hybridization followed by proximity ligation assay (a.k.a. Duolink®) and cell imaging to visualize DNA-methylation (5meC) on the SEPTIN9 promoter. SEPTIN9 promoter methylation is a known biomarker for colon cancer. After optimizing cross-linking, cell permeabilization and chromatin accessibility, the genomic specificity was ascertained by hybridizing with a pool of biotinylated-oligo probes that target the CpG islands in the human SEPTIN9 promoter. The Duolink assay was performed using anti-biotin and anti-5meC antibodies, corresponding proximity ligation assay probes, and Far Red detection reagents.
    Imaging by fluorescent microscopy revealed two red punctate spots in metastatic prostate cancer DU145 cells (diploid for chromosome 17 – location of SEPTIN9 gene) and three red spots in colon cancer SW480 cells (triploid for Chr17). No signal was observed in normal cells (BJ) or with non-specific oligo probes (LacZ). A decrease in Duolink signal was observed when the DU145 cells were treated with 5-AzaC, a drug known to block DNA-methylation. This proof of concept study will be extended to frozen and formalin fixed paraffin embedded human cancer tissue samples.
    Fluorescent imaging data will also be presented from a Duolink assay to monitor the interaction of EZH2 histone methyltransferase with the H3K27me3 epigenetic mark in prostate cancer (DU145) cells. Reduction in the Duolink signal demonstrated inhibition of EZH2 activity by the small molecule inhibitors SAHA and GSK343.
  • Visualizing DNA Methylation (5mC) on a Specific Genomic Locus (SEPTIN9) 01 Apr 14 2015 1:00 am UTC 75 mins
    Although there are many techniques to study epigenetic marks such as DNA- and histone-methylation, on a genomic scale, there exists a need in the field to visualize these epigenetic marks at a single genomic locus in individual cells. Such an application requires a highly sensitive detection method. With this aim, a protocol was developed to perform in-situ hybridization followed by proximity ligation assay (a.k.a. Duolink®) and cell imaging to visualize DNA-methylation (5meC) on the SEPTIN9 promoter. SEPTIN9 promoter methylation is a known biomarker for colon cancer. After optimizing cross-linking, cell permeabilization and chromatin accessibility, the genomic specificity was ascertained by hybridizing with a pool of biotinylated-oligo probes that target the CpG islands in the human SEPTIN9 promoter. The Duolink assay was performed using anti-biotin and anti-5meC antibodies, corresponding proximity ligation assay probes, and Far Red detection reagents.
    Imaging by fluorescent microscopy revealed two red punctate spots in metastatic prostate cancer DU145 cells (diploid for chromosome 17 – location of SEPTIN9 gene) and three red spots in colon cancer SW480 cells (triploid for Chr17). No signal was observed in normal cells (BJ) or with non-specific oligo probes (LacZ). A decrease in Duolink signal was observed when the DU145 cells were treated with 5-AzaC, a drug known to block DNA-methylation. This proof of concept study will be extended to frozen and formalin fixed paraffin embedded human cancer tissue samples.
    Fluorescent imaging data will also be presented from a Duolink assay to monitor the interaction of EZH2 histone methyltransferase with the H3K27me3 epigenetic mark in prostate cancer (DU145) cells. Reduction in the Duolink signal demonstrated inhibition of EZH2 activity by the small molecule inhibitors SAHA and GSK343.
  • Late Stage Functionalization of Drug-Like Molecules Session 2 Mar 31 2015 3:00 pm UTC 45 mins
    C-H functionalization is a powerful addition to the toolbox of the medicinal chemist. Modern C-H functionalization techniques hold the potential to enable the rapid exploration of structure activity relationships (SAR), the generation of oxidized metabolites, the blocking of metabolic hot spots and the preparation of biological probes. This presentation will describe a variety of high-value C-H functionalization chemistries, developed in house and in collaboration with academic groups, and give examples of how these technologies have been deployed successfully to impact drug discovery programs.
  • Late Stage Functionalization of Drug-Like Molecules Session 1 Mar 31 2015 1:00 am UTC 45 mins
    C-H functionalization is a powerful addition to the toolbox of the medicinal chemist. Modern C-H functionalization techniques hold the potential to enable the rapid exploration of structure activity relationships (SAR), the generation of oxidized metabolites, the blocking of metabolic hot spots and the preparation of biological probes. This presentation will describe a variety of high-value C-H functionalization chemistries, developed in house and in collaboration with academic groups, and give examples of how these technologies have been deployed successfully to impact drug discovery programs.
  • Molecular Annotation of EGFR Signaling-Associated Complexes in Human Cancer 02 Mar 26 2015 3:00 pm UTC 75 mins
    Mass spectrometry and other methods such as yeast two-hybrid can now accurately discern protein complexes or larger protein interactomes in diseases such as cancer, yet it is difficult to forward translate this knowledge into human samples. To overcome this hurdle, we began experiments using proximity ligation assays (PLA) to directly translate protein complexes into human tumor materials. Our assay reflects protein complexes between EGFR and GRB2 protein, a key adaptor protein necessary for EGFR pathway activation and coupling to downstream MAPK signaling. We annotated nearly 300 primary xenograft models (PDX) of cancer and show tumor subtype enrichment of EGFR:GRB2 signaling-associated complexes. Furthermore, tumors with abundant levels of EGFR:GRB2 signaling-associated complexes are more likely to respond to anti-EGFR antibody-based therapy. Finally, in 350 lung cancer tissues, across three distinct cohorts of patients, we demonstrate the ability of EGFR:GRB2 protein complexes to segregate tumors and show benefit to EGFR tyrosine kinase inhibitor therapy in patients whose tumors harbor high levels of EGFR:GRB2 signaling-associated complexes. This suggests that annotation of signaling-associated protein complexes in cancer tissues can not only molecularly annotate disease types but may also have predictive capacity for cancer therapeutics. This work opens up the human protein interactome as a new class of molecular markers for disease in a more practical manner. Proteins, encoded by DNA, do not work in isolation but instead function as part of multi-protein complexes that drive both normal and disease physiology. While we demonstrate the utility of this approach in cancer, receptor tyrosine kinase signaling and tyrosine kinase inhibitor therapeutics, our approach described here could have utility across a wide spectrum of both signaling-associated complexes and different types of disease, and thus would be attractive to a large audience.
  • Why We Use Cell Lines as Models: A 30 Year Journey and What Lies Ahead Mar 26 2015 1:45 pm UTC 60 mins
    This webinar will discuss the evolving role of Cell Lines and Cell Culture and their usefulness as models of physiological function and disease. The webinar will review the depth, breadth and best use of currently available Cell Lines. The role played by Cell Lines in ensuring that the output of future research continues to be valid and credible will also be evaluated. This is the first of a three part webinar series focused on delivering a broad picture of the role of cell lines as models in scientific research, the various strategies and approaches available.
  • Molecular Annotation of EGFR Signaling-Associated Complexes in Human Cancer 01 Mar 25 2015 7:00 pm UTC 75 mins
    Mass spectrometry and other methods such as yeast two-hybrid can now accurately discern protein complexes or larger protein interactomes in diseases such as cancer, yet it is difficult to forward translate this knowledge into human samples. To overcome this hurdle, we began experiments using proximity ligation assays (PLA) to directly translate protein complexes into human tumor materials. Our assay reflects protein complexes between EGFR and GRB2 protein, a key adaptor protein necessary for EGFR pathway activation and coupling to downstream MAPK signaling. We annotated nearly 300 primary xenograft models (PDX) of cancer and show tumor subtype enrichment of EGFR:GRB2 signaling-associated complexes. Furthermore, tumors with abundant levels of EGFR:GRB2 signaling-associated complexes are more likely to respond to anti-EGFR antibody-based therapy. Finally, in 350 lung cancer tissues, across three distinct cohorts of patients, we demonstrate the ability of EGFR:GRB2 protein complexes to segregate tumors and show benefit to EGFR tyrosine kinase inhibitor therapy in patients whose tumors harbor high levels of EGFR:GRB2 signaling-associated complexes. This suggests that annotation of signaling-associated protein complexes in cancer tissues can not only molecularly annotate disease types but may also have predictive capacity for cancer therapeutics. This work opens up the human protein interactome as a new class of molecular markers for disease in a more practical manner. Proteins, encoded by DNA, do not work in isolation but instead function as part of multi-protein complexes that drive both normal and disease physiology. While we demonstrate the utility of this approach in cancer, receptor tyrosine kinase signaling and tyrosine kinase inhibitor therapeutics, our approach described here could have utility across a wide spectrum of both signaling-associated complexes and different types of disease, and thus would be attractive to a large audience.
  • Integrating the Proximity Ligation Assay (PLA) into your Research Program 02 Mar 17 2015 3:00 pm UTC 75 mins
    The proximity ligation assay (PLA) is a powerful technique for performing in situ analysis of antibody targets in cells or tissues. This antibody-based application is very robust, and will provide unique data on localization and/or interaction of proteins. The webinar will outline the development of PLA, using an approach that is designed to help all researchers—regardless of their level of experience with this application. Topics addressed will include the following: guidelines for getting started, tips on the crucial bioinformatics investigations involved with the planning phase, specific details on the bench-work associated with performing the assay, and troubleshooting suggestions to allow investigators to refine the assay and successfully integrate it into their research program.
  • Integrating the Proximity Ligation Assay (PLA) into your Research Program 01 Mar 17 2015 1:00 am UTC 75 mins
    The proximity ligation assay (PLA) is a powerful technique for performing in situ analysis of antibody targets in cells or tissues. This antibody-based application is very robust, and will provide unique data on localization and/or interaction of proteins. The webinar will outline the development of PLA, using an approach that is designed to help all researchers—regardless of their level of experience with this application. Topics addressed will include the following: guidelines for getting started, tips on the crucial bioinformatics investigations involved with the planning phase, specific details on the bench-work associated with performing the assay, and troubleshooting suggestions to allow investigators to refine the assay and successfully integrate it into their research program.
  • Introduction to PLA and Duolink Session 2 Mar 10 2015 3:00 pm UTC 75 mins
    Visualization of protein-protein interactions at endogenous levels of expression is a powerful advancement in Life Science. Duolink® is a versatile tool for detection, quantification and localization of cytoplasmic signaling events. PLA® provides the ability to see and quantitate protein posttranslational modifications, define complex interactions, illuminate complex protein clusters or amplify low abundant single events.
  • Introduction to PLA and Duolink Session 1 Mar 10 2015 1:00 am UTC 75 mins
    Visualization of protein-protein interactions at endogenous levels of expression is a powerful advancement in Life Science. Duolink® is a versatile tool for detection, quantification and localization of cytoplasmic signaling events. PLA® provides the ability to see and quantitate protein posttranslational modifications, define complex interactions, illuminate complex protein clusters or amplify low abundant single events.
  • Modifying Cell Lines for Target Discovery and Validation Mar 3 2015 4:00 pm UTC 45 mins
    Recent advances in genome editing have opened new potential for a wide variety of specific genomic modifications in virtually any cell type. In this 30-minute seminar, we will discuss the process of genome editing, address factors affecting the design of a genome editing project, and explore the application of modified cell lines for target discovery and validation.
  • Purification & Workup of Organic Synthesis - Basics, Strategies & Methodology Recorded: Nov 6 2014 68 mins
    Workup and purification can be a complicated and time consuming process. The webinar will offer some available options for streamlining this part of your workflow, and provide some guidance and strategic advice depending on budget, equipment and experience. Workup of aqueous fractions will also be discussed.

    With the need for results as quickly as possible we will discuss how to perform reaction monitoring as quickly as possible using standard HPLC systems. We will show, with an example, how you may be able to obtain your results in 1/3 of your current time if you are running isocratically, or with generic gradients, with 5um or 3um C18 HPLC columns.
  • 3D Cell Culture Innovations Session 2 Recorded: Nov 4 2014 58 mins
    This 1 hour long webinar will cover innovations in 3D cell culture technologies. Technology experts will discuss the unique features of the Perfecta3D Hanging Drop Plates and Cell-in-a-Box live cell encapsulation system with special emphasis on research applications and techniques.

    Topics will include:
    •Overview of the Perfecta3D plates and Cell-in-a-Box system
    •3D culture system selection
    •Best practices
    •Research Applications
  • 3D Cell Culture Innovations Session 1 Recorded: Nov 4 2014 55 mins
    This 1 hour long webinar will cover innovations in 3D cell culture technologies. Technology experts will discuss the unique features of the Perfecta3D Hanging Drop Plates and Cell-in-a-Box live cell encapsulation system with special emphasis on research applications and techniques.

    Topics will include:
    •Overview of the Perfecta3D plates and Cell-in-a-Box system
    •3D culture system selection
    •Best practices
    •Research Applications
  • Sigma CRISPR Paired Nickases for Genome Editing Session 2 Recorded: Oct 28 2014 30 mins
    This 30 minute webinar will describe the function, design and application of CRISPR paired nickases. A Sigma-Aldrich® technology expert will discuss unique features of CRISPR paired nickases with special attention to specificity and design density critical to genome editing experiments.
    Topics will include:
    •Introduction to CRISPR paired nickase
    •Enhanced CRISPR target specificity of Cas9D10A
    •Design density in small target regions with paired nickase
    •Integration of donor constructs using paired nickase
    •CRISPR paired nickase as a tool to introduce disease-relevant single nucleotide polymorphisms (snps)
Focusing on new / innovative technologies and industry challenges
The Sigma-Aldrich seminar series features scientific presentations from key specialists in analytical chemistry, chemistry and life sciences, on the practical and technical aspects of new developments and innovations, to help advance your research.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Ultra-Fast LC/MS/MS in Bioanalysis Using Fused-Core Columns
  • Live at: Feb 16 2011 4:00 pm
  • Presented by: Ethan R. Badman, Ph.D.
  • From:
Your email has been sent.
or close
You must be logged in to email this